The TGF-β signaling pathway significantly influences inflammation by modulating Th cell differentiation and reducing JMJD3-mediated production of cytokines such as IL-2, IL-4, and IFN-γ, as evidenced in systemic sclerosis (SSc) [53]. Here, KDM6B is linked to systemic sclerosis.